Introducing the new anti-influenza drug, baloxavir marboxil
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference11 articles.
1. Antivirals targeting the polymerase complex of influenza viruses;Mifsud;Antivir Res,2019
2. Baloxavir Marboxil Investigators Group. Baloxavir marboxil for uncomplicated influenza in adults and adolescents;Hayden;N Engl J Med,2018
3. Phase 3 trial of baloxavir marboxil in high risk influenza patients (CAPSTONE-2 study);Ison,2018
4. Safety, tolerability, and pharmacokinetics of the novel anti-influenza agent baloxavir marboxil in healthy adults: phase I study findings;Koshimichi;Clin Drug Investig,2018
5. Single-dose inhaled laninamivir: registered in Japan and its potential role in control of influenza epidemics;Sunagawa;Influenza Other Respir Viruses,2013
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Kinetic degradation study for the first licensed anti‐influenza polymerase inhibitor, baloxavir marboxil, using high‐performance liquid chromatography‐mass spectrometry;Journal of Separation Science;2022-05-20
2. Baloxavir Marboxil Polymorphs: Investigating the Influence of Molecule Packing on the Dissolution Behavior;Crystals;2022-04-15
3. Role of zanamivir is likely to end in Okinawa, Japan;Respiratory Investigation;2021-01
4. A retrospective observational study of the treatment of a nosocomial infection caused by oseltamivir-resistant influenza virus A with baloxavir marboxil;Respiratory Investigation;2020-09
5. Clinical application of baloxavir marboxil in the treatment of influenza;Respiratory Investigation;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3